| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 630,000 | 493,000 | 904,000 | 795,000 | | Cost of Revenue | 368,000 | 429,000 | 503,000 | 515,000 | | | Gross Profit | 262,000 | 64,000 | 401,000 | 280,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,000 | 45,000 | 38,000 | 31,000 | | Non Recurring | 125,000 | 405,000 | 438,000 | 48,000 | | Others | 72,000 | 94,000 | 92,000 | 94,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,000 | (480,000) | (167,000) | 107,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,000 | 4,000 | 4,000 | 38,000 | | Earnings Before Interest And Taxes | 17,000 | (463,000) | (155,000) | 39,000 | | Interest Expense | 115,000 | 98,000 | 98,000 | 105,000 | | Income Before Tax | (98,000) | (561,000) | (253,000) | (66,000) | | Income Tax Expense | (23,000) | (209,000) | 85,000 | (56,000) | | Minority Interest | 14,000 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (75,000) | (352,000) | (338,000) | (10,000) | | | Non-recurring Events | | Discontinued Operations | (148,000) | 6,000 | 1,000 | 3,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (209,000) | (346,000) | (337,000) | (7,000) | | Preferred Stock And Other Adjustments | (3,000) | 1,000 | 2,000 |
-
| | | Net Income Applicable To Common Shares | ($212,000) | ($345,000) | ($335,000) | ($7,000) |
|
0.11% Nasdaq 0.00%
Income Statement
